QRxPharma : Appendix 4C - Quarter Ended 30 September 2016

+Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

QRxPharma Limited

16 102 254 151

30 September 2016

1. Cash flows from investing activities

2. Payments to acquire:

3. property, plant and equipment - -

4. businesses (see item 10) - -

5. investments - -

Consolidated statement of cash flows	Current quarter $A'000	Year to date (3 months) $A'000
(d) intellectual property	-	-
(e) other non-current assets	-	-
2.2 Proceeds from disposal of:
(a) property, plant and equipment	-	-
(b) businesses (see item 10)	-	-
(c) investments	-	-
(d) intellectual property	-	-
(e) other non-current assets	-	-
2.3 Cash flows from loans to other entities	-	-
2.4 Dividends received (see note 3)	-	-
2.5 Other (provide details if material)	-	-
2.6 Net cash from / (used in) investing	-	-
activities

Cash flows from financing activities Proceeds from issues of shares Proceeds from issue of convertible notes Proceeds from exercise of share options Transaction costs related to issues of shares, convertible notes or options Proceeds from borrowings Repayment of borrowings Transaction costs related to loans and borrowings Dividends paid Other (provide details if material) 3.10 Net cash from / (used in) financing activities	- - - - - - - - -	- - - - - - - - -
	-	-

1. Net increase / (decrease) in cash and cash equivalents for the period

2. Cash and cash equivalents at beginning of quarter/year to date

3. Net cash from / (used in) operating

   1,194 1,194

   activities (item 1.9 above) (256)(256)

4. Net cash from / (used in) investing activities

   (item 2.6 above) --

5. Net cash from / (used in) financing activities

(item 3.10 above) --

Consolidated statement of cash flows	Current quarter $A'000	Year to date (3 months) $A'000
4.5 Effect of movement in exchange rates on cash held 4.6 Cash and cash equivalents at end of quarter	(4)	(4)
	934	934

5. Reconciliation of cash and cash	Current quarter	Previous quarter
equivalents	$A'000	$A'000
at the end of the quarter (as shown in the
consolidated statement of cash flows) to the
related items in the accounts
5.1 Bank balances	934	1,194
5.2 Call deposits	-	-
5.3 Bank overdrafts	-	-
5.4 Other (provide details)	-	-
5.5 Cash and cash equivalents at end of	934	1,194
quarter (should equal item 4.6 above)

Current quarter $A'000

15

-

1. Payments to directors of the entity and their associates

2. Aggregate amount of payments to these parties included in item 1.2

3. Aggregate amount of cash flow from loans to these parties included in item 2.3

4. Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

   Payments represent director's fees.

   Current quarter $A'000

   -

   -

5. Payments to related entities of the entity and their associates

6. Aggregate amount of payments to these parties included in item 1.2

7. Aggregate amount of cash flow from loans to these parties included in item 2.3

8. Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

   Total facility amount at quarter end $A'000	Amount drawn at quarter end $A'000
   -	-
   -	-
   -	-

9. Financing facilities available Add notes as necessary for an understanding of the position

10. Loan facilities

11. Credit standby arrangements

12. Other (please specify)

13. Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

9. Estimated cash outflows for next quarter	$A'000
9.1 Research and development	-
9.2 Product manufacturing and operating costs	-
9.3 Advertising and marketing	-
9.4 Leased assets	-
9.5 Staff costs	60
9.6 Administration and corporate costs	108
9.7 Other (provide details if material)	-
9.8 Total estimated cash outflows	168

10. Acquisitions and disposals of business entities (items 2.1(b) and 2.2(b) above)	Acquisitions	Disposals
10.1 Name of entity	-	-
10.2 Place of incorporation or registration	-	-
10.3 Consideration for acquisition or disposal	-	-
10.4 Total net assets	-	-
10.5 Nature of business	-	-